BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16436990)

  • 1. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level.
    Neff BA; Welling DB; Akhmametyeva E; Chang LS
    Otol Neurotol; 2006 Feb; 27(2):197-208. PubMed ID: 16436990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular studies of vestibular schwannomas: a review.
    Welling DB; Packer MD; Chang LS
    Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):341-6. PubMed ID: 17823551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular biology and novel treatments of vestibular schwannomas.
    Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
    J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
    Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
    Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
    Halum SL; Erbe CB; Friedland DR; Wackym PA
    Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genesis and biology of vestibular schwannomas.
    Roche PH; Bouvier C; Chinot O; Figarella-Branger D
    Prog Neurol Surg; 2008; 21():24-31. PubMed ID: 18810196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.
    Koutsimpelas D; Ruerup G; Mann WJ; Brieger J
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):33-7. PubMed ID: 22249120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.
    Akhmametyeva EM; Mihaylova MM; Luo H; Kharzai S; Welling DB; Chang LS
    Dev Dyn; 2006 Oct; 235(10):2771-85. PubMed ID: 16894610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
    Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
    Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics.
    Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT
    J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on Tumor Biology in Vestibular Schwannoma.
    Nourbakhsh A; Dinh CT
    Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
    Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
    Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.